King Wealth Novo Nordisk A S Transaction History

King Wealth

$686 Million
Q4 2024

A detailed history of King Wealth transactions in Novo Nordisk A S stock. As of the latest transaction made, King Wealth holds 2,379 shares of NVO stock, worth $182,849. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,379

Holding current value

$182,849

% of portfolio

0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 10, 2025	BUY	$85.0 - $120.04 $202,215 - $285,575	2,379 New	2,379 $205,000
Q2 2024 Aug 08, 2024	SELL	$122.71 - $146.91 $10,675 - $12,781	-87 Reduced 0.59%	14,784 $2.11 Million
Q1 2024 May 09, 2024	SELL	$102.11 - $135.92 $374,845 - $498,962	-3,671 Reduced 19.8%	14,871 $1.91 Million
Q4 2023 Feb 08, 2024	BUY	$87.78 - $105.45 $1.06 Million - $1.27 Million	12,061 Added 186.1%	18,542 $1.92 Million
Q3 2023 Nov 09, 2023	SELL	$90.94 - $199.54 $161,600 - $354,582	-1,777 Reduced 21.52%	6,481 $589,000
Q2 2023 Aug 10, 2023	BUY	$155.98 - $172.65 $155 - $172	1 Added 0.01%	8,258 $1.34 Million
Q1 2023 May 10, 2023	BUY	$132.34 - $159.14 $13,234 - $15,913	100 Added 1.23%	8,257 $1.31 Million
Q4 2022 Feb 09, 2023	SELL	$102.55 - $135.33 $299,446 - $395,163	-2,920 Reduced 26.36%	8,157 $1.1 Million
Q3 2022 Nov 10, 2022	BUY	$95.28 - $116.93 $288,698 - $354,297	3,030 Added 37.65%	11,077 $1.1 Million
Q2 2022 Aug 11, 2022	BUY	$103.24 - $121.81 $516,200 - $609,050	5,000 Added 164.1%	8,047 $897,000
Q1 2022 May 12, 2022	SELL	$93.1 - $112.54 $191,413 - $231,382	-2,056 Reduced 40.29%	3,047 $338,000
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $168,924 - $213,346	2,001 Added 64.51%	5,103 $490,000
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $201,180 - $227,459	-3,000 Reduced 49.16%	3,102 $209,000
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $677,234 - $782,280	-10,600 Reduced 63.47%	6,102 $426,000
Q3 2020 Nov 12, 2020	BUY	$63.69 - $70.22 $636,963 - $702,270	10,001 Added 149.25%	16,702 $1.16 Million
Q2 2020 Aug 13, 2020	BUY	$58.54 - $67.94 $58 - $67	1 Added 0.01%	6,701 $439,000
Q4 2019 Feb 13, 2020	BUY	$49.86 - $58.26 $334,062 - $390,342	6,700 New	6,700 $388,000

Others Institutions Holding NVO

# of Institutions

1,885

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

Jennison Associates LLC

19.9M
Shares

$1.53 Billion
1.06% of portfolio
Bank Of America Corp Charlotte, NC

15.5M
Shares

$1.19 Billion
0.11% of portfolio
Gqg Partners LLC Ft. Lauderdale, FL

13M
Shares

$999 Million
1.67% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

12.6M
Shares

$972 Million
0.44% of portfolio
Morgan Stanley New York, NY

12.2M
Shares

$938 Million
0.08% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $173B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

News

Stay updated on King Wealth with notifications on news.

Account